PLIVA FDA Approval ANDA 065246

ANDA 065246

PLIVA

FDA Drug Application

Application #065246

Documents

Letter2006-07-13

Application Sponsors

ANDA 065246PLIVA

Marketing Status

Prescription001
Prescription002

Application Products

001FOR SUSPENSION;ORALEQ 200MG BASE/5ML0AZITHROMYCINAZITHROMYCIN
002FOR SUSPENSION;ORALEQ 100MG BASE/5ML0AZITHROMYCINAZITHROMYCIN

FDA Submissions

ORIG1AP2006-07-06
LABELING; LabelingSUPPL5AP2009-10-22
LABELING; LabelingSUPPL7AP2009-09-28
LABELING; LabelingSUPPL11AP2012-02-28
LABELING; LabelingSUPPL14AP2012-12-18STANDARD
LABELING; LabelingSUPPL15AP2013-02-28STANDARD
LABELING; LabelingSUPPL16AP2013-07-11STANDARD
LABELING; LabelingSUPPL19AP2017-06-28STANDARD
LABELING; LabelingSUPPL22AP2017-06-28STANDARD
LABELING; LabelingSUPPL23AP2017-06-28STANDARD
LABELING; LabelingSUPPL24AP2017-06-28STANDARD
LABELING; LabelingSUPPL25AP2020-01-13STANDARD
LABELING; LabelingSUPPL26AP2020-01-13STANDARD

Submissions Property Types

SUPPL7Null7
SUPPL11Null15
SUPPL14Null15
SUPPL15Null15
SUPPL16Null15
SUPPL19Null15
SUPPL22Null7
SUPPL23Null7
SUPPL24Null15
SUPPL25Null15
SUPPL26Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65246
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 200MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 100MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AZITHROMYCIN","submission":"AZITHROMYCIN","actionType":"EQ 200MG BASE\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"AZITHROMYCIN","submission":"AZITHROMYCIN","actionType":"EQ 100MG BASE\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.